Gradientech

Gradientech develops innovative solutions for clinical microbiology laboratories to facilitate their work with time-critical sepsis tests and shorten the testing time. Gradientech develops the diagnostic system QuickMIC® – a new platform for ultra-fast antibiotic resistance testing based on phenotypic bacterial growth analysis. The system is expected to be the fastest solution for determining the appropriate antibiotic treatment for sepsis patients. Rapid antibiotic resistance testing is crucial for increasing the chance of sepsis patient survival, reducing healthcare costs and slowing the spread of antibiotic resistance in society.